Last Posted: Nov 02, 2020
- Genetic analyses of a large cohort of infertile patients with globozoospermia, DPY19L2 still the main actor, GGN confirmed as a guest player.
Celse Tristan, et al. Human genetics 2020 10
- Corrigendum to: Deletion of dpy-19 like 2 (DPY19L2) gene is associated with total but not partial globozoospermia.
Alimohammadi Fatemeh, et al. Reproduction, fertility, and development 2020 5 (8) 805
- Deletion of dpy-19 like 2 (DPY19L2) gene is associated with total but not partial globozoospermia.
Alimohammadi Fatemeh, et al. Reproduction, fertility, and development 2020 4
- Comparison of sperm morphology and nuclear sperm quality in SPATA16- and DPY19L2-mutated globozoospermic patients.
Ghédir Houda, et al. Andrologia 2019 3 e13277
- DNAH6 is a novel candidate gene associated with sperm head anomaly.
Li L, et al. Andrologia 2018 1
- Assessment of DPY19L2 Deletion in Familial and Non-Familial Individuals with Globozoospermia and DPY19L2 Genotyping.
Modarres Parastoo, et al. International journal of fertility & sterility 0 0 (2) 196-207
- Identification of a new DPY19L2 mutation and a better definition of DPY19L2 deletion breakpoints leading to globozoospermia.
Ghédir Houda, et al. Molecular human reproduction 2015 10
- Mutations of the aurora kinase C gene causing macrozoospermia are the most frequent genetic cause of male infertility in Algerian men.
Ounis Leyla, et al. Asian journal of andrology 0 0 (1) 68-73
- Assisted oocyte activation overcomes fertilization failure in globozoospermic patients regardless of the DPY19L2 status.
Kuentz P, et al. Human reproduction (Oxford, England) 2013 4 (4) 1054-61
From NCATS Genetic and Rare Diseases Information Center
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.